ABSTRACT
AIM: To report the endoscopic treatment of large hyperplastic polyps of the esophagus and esophago-gastric junction (EGJ) associated with Barrett's esophagus (BE) with low-grade dysplasia (LGD), by endoscopic mucosal resection (EMR). METHODS: Cap fitted EMR (EMR-C) was performed in 3 patients with hyperplastic-inflammatory polyps (HIPs) and BE. RESULTS: The polyps were successfully removed in the 3 patients. In two patients, with short segment BE (SSBE) (<= 3 cm), the metaplastic tissue was completely excised. A 2 cm circumferential EMR was performed in one patient with a polyp involving the whole EGJ. A simultaneous EMR-C of a BE-associated polypoid dysplastic lesion measuring 1 cm multiply 10 cm, was also carried out. In the two patients, histologic assessment detected LGD in BE. No complications occurred. Complete neosquamous re-epithelialization occurred in the two patients with SSBE. An esophageal recurrence occurred in the remaining one and was successfully retreated by EMR. CONCLUSION: EMR-C appears to be a safe and effective method for treating benign esophageal mucosal lesions, allowing also the complete removal of SSBE.
Subject(s)
Barrett Esophagus/surgery , Endoscopy, Gastrointestinal/methods , Esophageal Diseases/pathology , Esophageal Diseases/surgery , Polyps/pathology , Polyps/surgery , Aged , Barrett Esophagus/complications , Barrett Esophagus/pathology , Esophagogastric Junction/pathology , Esophagogastric Junction/surgery , Esophagus/pathology , Esophagus/surgery , Female , Humans , Hyperplasia/pathology , Male , Middle Aged , Minimally Invasive Surgical Procedures/methods , Mucous Membrane/pathology , Mucous Membrane/surgery , Polyps/etiologySubject(s)
Esophageal Neoplasms/surgery , Esophagoscopy , Granular Cell Tumor/surgery , Esophageal Neoplasms/diagnostic imaging , Esophageal Neoplasms/pathology , Granular Cell Tumor/diagnostic imaging , Granular Cell Tumor/pathology , Humans , Male , Middle Aged , Mucous Membrane/diagnostic imaging , Mucous Membrane/pathology , Mucous Membrane/surgery , UltrasonographyABSTRACT
Vascular endothelial growth factor (VEGF) is known to play a key role in tumour angiogenesis. Our preliminary published data suggest that plasma-activated platelets rich (P-APR) rather than other plasma compartments (i.e. plasma, plasma-platelets poor) or serum is the more suitable blood fraction for measuring VEGF in a miscellaneous series of gastrointestinal cancer patients. The aim of this confirmatory study was to assess VEGF in P-APR blood compartments of 30 healthy control subjects (HCS) and a homogeneous series of 62 colorectal cancer patients (CRCP), prospectively collected, to evaluate its possible clinical-biological significance. Samples of plasma (P) in both sodium citrate (SC) and sodium citrate-theophylline-adenosine-dipyridamole (CTAD) were collected from venous blood. After the centrifugation and separation methods VEGF levels were detected by ELISA in P-APR. The best differentiation between HCS and CRCP in VEGF level was seen for P-APRCTAD (median value: 255 pg/ml versus 142 pg/ml; p=0.000 by Mann-Whitney U test). No significant correlation among the P-APR VEGF concentrations and the main clinical pathological features was found. We suggest that P-APRCTAD fraction, obtained according to well standardised conditions, could represent the suitable blood compartment for the assessment of VEGF as marker of malignant intestinal transformation.
